671 DRIVING ABILITY UNDER LONG-TERM TREATMENT WITH CONTROLLED RELEASE OXYCODONE IN NON-CANCER PAIN PATIENTS

2006 ◽  
Vol 10 (S1) ◽  
pp. S175b-S175
Author(s):  
O. Dagtekin ◽  
H.J. Gerbershagen ◽  
A. Delis ◽  
J. Gärtner ◽  
F. Petzke ◽  
...  
Keyword(s):  
Controlled Release ◽  
Cancer Pain ◽  
Term Treatment ◽  
Driving Ability ◽  
Long Term Treatment ◽  
Pain Patients

Results of long-term treatment with controlled-release levodopa/carbidopa (Sinemet CR)

1990 ◽  
Vol 2 (3) ◽  
pp. 205-213 ◽  
Author(s):  
J. M. Cedarbaum ◽  
M. Silvestri ◽  
M. Clark ◽  
L. Toy ◽  
A. Harts ◽  
...  
Keyword(s):  
Controlled Release ◽  
Term Treatment ◽  
Long Term Treatment

Assessing Cognitive and Psychomotor Performance Under Long-Term Treatment with Transdermal Buprenorphine in Chronic Noncancer Pain Patients

2007 ◽  
Vol 105 (5) ◽  
pp. 1442-1448 ◽  
Author(s):  
Oguzhan Dagtekin ◽  
Hans J. Gerbershagen ◽  
Werner Wagner ◽  
Frank Petzke ◽  
Lukas Radbruch ◽  
...  
Keyword(s):  
Psychomotor Performance ◽  
Term Treatment ◽  
Chronic Noncancer Pain ◽  
Long Term Treatment ◽  
Noncancer Pain ◽  
Pain Patients

scholarly journals Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients

2017 ◽  
Vol 78 (5-6) ◽  
pp. 320-329 ◽  
Author(s):  
Sebastian Schimrigk ◽  
Martin Marziniak ◽  
Christine Neubauer ◽  
Eva Maria Kugler ◽  
Gudrun Werner ◽  
...  
Keyword(s):  
Neuropathic Pain ◽  
Treatment Option ◽  
Term Treatment ◽  
Long Term Treatment ◽  
Pain Patients

scholarly journals Driving Ability Under Long-Term Treatment with Transdermal Fentanyl

2003 ◽  
Vol 25 (1) ◽  
pp. 38-47 ◽  
Author(s):  
Rainer Sabatowski ◽  
Susanne Schwalen ◽  
Klaus Rettig ◽  
Klaus W Herberg ◽  
Stephan M Kasper ◽  
...  
Keyword(s):  
Term Treatment ◽  
Driving Ability ◽  
Transdermal Fentanyl ◽  
Long Term Treatment

Oral Butorphanol Tartrate for the Long-Term Treatment of Out-Patients with Moderate to Severe Cancer Pain

1981 ◽  
Vol 9 (2) ◽  
pp. 124-127 ◽  
Author(s):  
Jaime De La Garza
Keyword(s):  
Blood Pressure ◽  
Cancer Pain ◽  
Open Study ◽  
Analgesic Efficacy ◽  
Term Treatment ◽  
Long Term Treatment ◽  
Clinically Significant ◽  
Oral Doses ◽  
Median Pain

The safety, tolerance and analgesic efficacy of multiple oral doses of butorphanol tartrate for the long-term treatment of cancer pain were evaluated in this open study. Thirty-five patients were treated with various doses (1 to 12 tablets per day) for 4 to 147 days. The median pain relief was fair, good, very good or excellent in 51% of the patients and poor in 49% of the patients. Global assessments were very similar. No clinically significant changes in blood pressure, weight, blood and urine chemistries were observed. Seventeen patients reported side-effects (only sedation and dry mouth) ranging from mild to severe.

scholarly journals Long-Term Treatment of Cancer Pain With Transdermal Fentanyl

1998 ◽  
Vol 15 (3) ◽  
pp. 168-175 ◽  
Author(s):  
Barbara Donner ◽  
Michael Zenz ◽  
Michael Strumpf ◽  
Manfred Raber
Keyword(s):  
Cancer Pain ◽  
Term Treatment ◽  
Transdermal Fentanyl ◽  
Long Term Treatment
Sign in / Sign up

Export Citation Format

Share Document